+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Cell Bioinformatics Software and Services Market - A Global and Regional Analysis: Focus on Product, Application, End-User, and Region - Analysis and Forecast, 2021-2031

  • PDF Icon

    Report

  • 206 Pages
  • April 2022
  • Region: Global
  • BIS Research
  • ID: 5578624

Global Single Cell Bioinformatics Software and Services Market to Reach $634.8 Million by 2031

The global single cell bioinformatics software and services market was estimated to be at $205.2 million in 2020, which is expected to grow with a CAGR of 10.89% and reach $634.8 million by 2031. The growth in the global single cell bioinformatics software and services market is expected to be driven by an increasing number of bioinformatics services being offered for computational analysis and a rising number of open-source free platform providers offering single cell analysis software.



Market Lifecycle Stage

The single cell bioinformatics software and services market is still in the nascent phase. Significant increases in the research and development activities pertaining to single cell analysis are underway to develop single cell bioinformatics software and services-based products, which are expected to increase due to the rising number of chronic disease burdens such as cancer. Researchers are generating data that have the potential to lead to unprecedented biological insight, albeit at the cost of the greater complexity of data analysis. Increasing investments in the R&D of cell bioinformatics software and services and various research fundings is one of the major opportunities in the global cell bioinformatics software and services market.

Impact

  • The presence of major service providers of single cell bioinformatics and services in regions such as North America and Europe has a major impact on the market. For instance, Illumina, Inc. provides clinical sequencing bioinformatics services. The service includes TruGenome undiagnosed disease test, a clinical whole-genome sequencing test for patients with a suspected rare and undiagnosed genetic disease.
  • Companies such as QIAGEN provide QIAGEN discovery bioinformatics services. The services are a reliable and convenient way to expand in-house resources with expertise and perfectly tailored bioinformatics services that ensure quality results. The presence of these companies has a positive impact on the market growth.

Impact of COVID-19

Most of the single cell studies focused on the progression of COVID-19 and have provided important molecular and immune characteristics. Researchers have analyzed large-scale single cell integrated data, which included single cell sequencing data of 140 different types of samples from 104 COVID-19 patients. Through this, they gained insights into the immune cell proportions of peripheral blood mononuclear cells (PBMCs), Tcell receptor (TCR) clone diversity, and other characteristics in convalescent patients. Another research study showcased profiled adaptive immune cells of PBMCs from recovered COVID-19 patients who have varying disease severity using single cell RNA sequencing, single cell TCR sequencing, and single cell BCR sequencing. Scientists have discovered a phenomenon that is hard to explain by these studies, which shows that convalescent patients with high serum anti-spike titers produce a higher proportion of non-neutralizing antibodies. Researchers have also performed single cell RNA sequencing on COVID-19 patient samples, which helped them compare the differences in gene expression patterns in patients of varying infection severity and in different organ types to analyze organ injury. They also found that COVID-19 infection leads to the inflammation of genes and pathways, which result in organ tissue damage to the liver, lungs, kidney, and heart. Through their study, they concluded that treating these symptoms at the organ level with therapeutic targets in the inflammatory pathway’s axis can lead to a better prognosis for severely infected patients.

Market Segmentation

by Products (Bioinformatics Software, Bioinformatics Services)

The global single cell bioinformatics software and services market in the products segment is expected to be dominated by the bioinformatics services segment. This is due to an increasing number of bioinformatics service providers offering services to their end users.

by Applications (Oncology, Immunology, Neurology, Non-invasive Prenatal Diagnosis (NIPD), Microbiology, Other Applications)

The global single cell bioinformatics software and services market is dominated by the oncology segment owing to an increasing number of patients suffering from cancer. According to the data published by World Health Organization, cancer is a leading cause of death, with nearly 10 million deaths reported in 2020.

by End-User (Research and Academic Institutes, Biopharmaceutical Companies, Others)

The research and academic institutes segment dominates the global single cell bioinformatics software and services market due to the increasing research and development activities in academic institutes and the focus of researchers on single cell analysis.

by Region

  • North America - U.S., Canada
  • Europe - U.K., Germany, France, Italy, Spain, and Rest-of-Europe
  • Asia-Pacific - Japan, China, India, South Korea, Australia, and Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico, and Rest of Latin America
  • Rest-of-the-World

North America generated the highest revenue of $103.0 million in 2020, which is attributed to the R&D advancements in the field of single cell analysis and the presence of dominating players operating in the single cell bioinformatics and services market.

Recent Developments in Global Single Cell Bioinformatics Software and Services Market

  • In December 2019, Nanostring developed a strategic license for diagnostic equipment based on nCounter for single cell and rights to Veracyte for $50 million and Veracyte stock, plus up to $10 million after satisfying future events.
  • In June 2021, Bruker Corporation launched the Tims TOF SCP system to provide quantitative single-cell 4D-Proteomics.
  • In September 2019, IsoPlexis expanded the sales of its single-cell proteomic research platforms, IsoLight and IsoCode Chip, to the Japanese pharmaceutical and life sciences industry by partnering with BioStream Co.
  • In January 2021, the company launched a new standard in spatial biology for high-speed imaging of whole slides at single-cell and sub-cellular resolution.

Demand – Drivers and Limitations

Following are the demand drivers for the single cell bioinformatics software and services market:

  • Rapid Development in the Single Cell Technologies
  • Advancing Field of Disease Diagnosis and Drug Discovery
  • Investments by the Biopharmaceutical Companies

The market is expected to face some limitations too due to the following challenges:

  • Analytical Challenges in Metabolite Analysis
  • Lack of Spatial-Temporal Context
  • Barriers to Carry Out Effective Single Cell Analysis

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The product segment helps the reader understand the two types of products, i.e., single cell bioinformatics software and services. These services are the major focus of the study as these services are the target of market players in terms of revenue generation. Moreover, the study provides the reader with a detailed understanding of the different applications such as oncology, immunology, NIPT, microbiology, and others.

Growth/Marketing Strategy: The single cell RNA-sequencing requires a lengthy pipeline comprising RNA extraction, single cell sorting, reverse transcription, library construction, amplification, sequencing, and subsequent bioinformatic analysis. Bioinformatics analysis is carried out with the help of various open-source platforms along with various bioinformatics services. Companies are providing these services, which is a key for market players to excel in the current bioinformatics software and services market.

Competitive Strategy: Key players in the global single cell bioinformatics software and services market analyzed and profiled in the study have involved the single cell bioinformatics software and services-based product manufacturers that provide software and services. Moreover, a detailed competitive benchmarking of the players operating in the global single cell bioinformatics software and services market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The leading top segment players include single cell bioinformatics services manufacturers that capture around 95% of the presence in the market. Bioinformatics software contributes around 5% of the presence in the market.

Some of the prominent names established in this market are:

  • Illumina, Inc.
  • QIAGEN N.V.
  • BD
  • PacBio
  • Fluidigm Corporation
  • NanoString
  • Takara Bio Inc.
  • BGI
  • Oxford Nanopore Technologies plc
  • Partek, Incorporated
  • Akoya Biosciences, Inc.
  • IsoPlexis
  • Scipio Bioscience
  • Scailyte
  • BioBam Spain

Companies that are not a part of the above-mentioned pool have been well represented across different sections of the report (wherever applicable).

Frequently Asked Questions about the Global Single Cell Bioinformatics Software and Services Market

What is the estimated value of the Global Single Cell Bioinformatics Software and Services Market?

The Global Single Cell Bioinformatics Software and Services Market was estimated to be valued at $225.7 Million in 2021.

What is the growth rate of the Global Single Cell Bioinformatics Software and Services Market?

The growth rate of the Global Single Cell Bioinformatics Software and Services Market is 10.9%, with an estimated value of $634.8 Million by 2031.

What is the forecasted size of the Global Single Cell Bioinformatics Software and Services Market?

The Global Single Cell Bioinformatics Software and Services Market is estimated to be worth $634.8 Million by 2031.

Who are the key companies in the Global Single Cell Bioinformatics Software and Services Market?

Key companies in the Global Single Cell Bioinformatics Software and Services Market include Illumina, Inc., QIAGEN N.V., BD, PacBio, Fluidigm Corporation, NanoString, Takara Bio Inc., BGI and Partek, Incorporated.

Table of Contents

1 Market
1.1 Product Definition
1.1.1 Inclusion and Exclusion
1.1.2 Key Questions Answered in the Report

2 Research Methodology
2.1 Global Single Cell Bioinformatics Software and Services Market: Research Methodology
2.2 Data Sources
2.2.1 Primary Data Sources
2.2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Criteria for Company Profiling

3 Market Overview
3.1 Overview
3.1.1 Market Footprint and Growth Potential, $Million, 2020-2031
3.1.2 Future Potential
3.1.3 COVID-19 Impact on Market

4 Industry Insights
4.1 Patent Analysis
4.1.1 Patent Filing Trend
4.1.2 Patent Analysis (by Year)
4.1.3 Patent Analysis (by Region)
4.1.4 Patent Analysis (by Country)

5 Competitive Landscape
5.1 Competitive Landscape
5.1.1 Acquisitions
5.1.2 Synergistic Activities
5.1.3 Product Launches and Upgradations
5.1.4 Business Expansion
5.1.5 Fundings
5.1.6 Market Share Analysis (2019-2020)
5.1.7 Growth-Share Analysis (2019-2020)
5.1.7.1 Growth-Share Analysis by Application
5.1.7.2 Growth-Share Analysis by End-user

6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 Rapid Development in the Single Cell Technologies
6.3.2 Advancing Field of Disease Diagnosis and Drug Discovery
6.3.3 Investments by the Biopharmaceutical Companies
6.4 Market Restraints
6.4.1 Barriers to Carry Out Effective Single Cell Analysis
6.4.2 Analytical Challenges in Metabolite Analysis
6.4.3 Lack of Spatial-Temporal Context
6.5 Market Opportunities
6.5.1 Rising Number of Multi-Omics Approach in Single Cell Sequencing
6.5.2 Role of Spatial Transcriptomics in Single Cell Sequencing

7 Global Single Cell Bioinformatics Software and Services Market, by Product, $Million, 2020 - 2031
7.1 Overview
7.2 Bioinformatic Software
7.3 Bioinformatic Services
7.3.1 Genomics Analysis
7.3.2 Transcriptome Analysis
7.3.3 Metabolomics Analysis
7.3.4 Epigenomics Analysis
7.3.5 Proteomic Analysis
7.3.6 Others

8 Global Single Cell Bioinformatics Software and Services Market, by Application, $Million, 2020 - 2031
8.1 Overview
8.2 Oncology
8.3 Immunology
8.4 Neurology
8.5 Non-invasive Prenatal Diagnosis (NIPD)
8.6 Microbiology
8.7 Others

9 Global Single cell bioinformatics software and services Market, by End-User, $Million, 2020 - 2031
9.1 Overview
9.2 Biopharmaceutical Companies
9.3 Research and Academic Institutes
9.4 Others

10 Global Single Cell Bioinformatics Software and Services Market, by Region, $Million, 2020-2031
10.1 Overview
10.2 North America
10.2.1 North America Single Cell Bioinformatics Software and Services Market (by Application)
10.2.2 U.S.
10.2.3 Canada
10.3 Europe
10.3.1 Europe Single Cell Bioinformatics Software and Services Market (by Application)
10.3.2 Germany
10.3.3 France
10.3.4 U.K.
10.3.5 Italy
10.3.6 Spain
10.3.7 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 Asia-Pacific Single Cell Bioinformatics Software and Services Market (by Application)
10.4.2 Japan
10.4.3 China
10.4.4 Australia
10.4.5 India
10.4.6 South Korea
10.4.7 Rest-of-Asia-Pacific
10.5 Latin America
10.5.1 Latin America Single Cell Bioinformatics Software and Services Market (by Application)
10.5.2 Brazil
10.5.3 Mexico
10.5.4 Rest-of-Latin America
10.6 Rest-of-the-World
10.6.1 Rest-of-the-World Single Cell Bioinformatics Software and Services Market (by Application)

11 Company Profiles
11.1 Overview
11.2 Market Value Chain of Single Cell Bioinformatics Software and Services
11.3 Illumina, Inc.
11.3.1 Company Overview
11.3.2 Role of Illumina, Inc. in the Global Single Cell Bioinformatics Software and Services Market
11.3.3 Key Customers of the Company
11.3.4 Key Competitors of the Company
11.3.5 Financials
11.3.6 Key Insights About Financial Health of the Company
11.3.7 SWOT Analysis
11.4 QIAGEN N.V.
11.4.1 Company Overview
11.4.2 Role of QIAGEN N.V. in the Global Single Cell Bioinformatics Software and Services Market
11.4.3 Key Customers of the Company
11.4.4 Key Competitors of the Company
11.4.5 Financials
11.4.6 Key Insights About Financial Health of the Company
11.4.7 SWOT Analysis
11.5 BD.
11.5.1 Company Overview
11.5.2 Role of BD. in the Global Single Cell Bioinformatics Software and Services Market
11.5.3 Key Competitors of the Company
11.5.4 Financials
11.5.5 Key Insights About Financial Health of the Company
11.5.6 SWOT Analysis
11.6 PacBio
11.6.1 Company Overview
11.6.2 Role of PacBio in the Global Single Cell Bioinformatics Software and Services Market
11.6.3 Key Customers of the Company
11.6.4 Key Competitors of the Company
11.6.5 Financials
11.6.6 Key Insights About Financial Health of the Company
11.6.7 SWOT Analysis
11.7 Fluidigm Corporation
11.7.1 Company Overview
11.7.2 Role of Fluidigm Corporation in the Global Single Cell Bioinformatics Software and Services Market
11.7.3 Key Customers of the Company
11.7.4 Key Competitors of the Company
11.7.5 Financials
11.7.6 Key Insights About Financial Health of the Company
11.7.7 SWOT Analysis
11.8 NanoString
11.8.1 Company Overview
11.8.2 Role of NanoString in the Global Single Cell Bioinformatics Software and Services Market
11.8.3 Key Customers of the Company
11.8.4 Key Competitors of the Company
11.8.5 Financials
11.8.6 Key Insights About Financial Health of the Company
11.8.7 SWOT Analysis
11.9 Takara Bio Inc.
11.9.1 Company Overview
11.9.2 Role of Takara Bio Inc. in the Global Single Cell Bioinformatics Software and Services Market
11.9.3 Key Customers of the Company
11.9.4 Key Competitors of the Company
11.9.5 Financials
11.9.6 Key Insights About Financial Health of the Company
11.9.7 SWOT Analysis
11.1 BGI
11.10.1 Company Overview
11.10.2 Role of BGI in the Global Single Cell Bioinformatics Software and Services Market
11.10.3 Key Competitors of the Company
11.10.4 SWOT Analysis
11.11 Oxford Nanopore Technologies plc.
11.11.1 Company Overview
11.11.2 Role of Oxford Nanopore Technologies plc. in the Global Single Cell Bioinformatics Software and Services Market
11.11.3 Key Competitors of the Company
11.11.4 Financials
11.11.5 Key Insights About Financial Health of the Company
11.11.6 SWOT Analysis
11.12 Partek, Incorporated
11.12.1 Company Overview
11.12.2 Role of Partek, Incorporated in the Global Single Cell Bioinformatics Software and Services Market
11.12.3 SWOT Analysis
11.13 Akoya Biosciences, Inc.
11.13.1 Company Overview
11.13.2 Role of Akoya Biosciences, Inc. in the Global Single Cell Bioinformatics Software and Services Market
11.13.3 Key Customers of the Company
11.13.4 SWOT Analysis
11.14 IsoPlexis
11.14.1 Company Overview
11.14.2 Role of IsoPlexis in the Global Single Cell Bioinformatics Software and Services Market
11.14.3 Key Customers of the Company
11.14.4 SWOT Analysis
11.15 Scipio Bioscience
11.15.1 Company Overview
11.15.2 Role of Scipio Biosciences in the Global Single Cell Bioinformatics Software and Services Market
11.15.3 Key Customers of the Company
11.16 Scailyte
11.16.1 Company Overview
11.16.2 Role of Scailyte in the Global Single Cell Bioinformatics Software and Services Market
11.17 BioBam Spain
11.17.1 Company Overview
11.17.2 Role of BioBam Spain in the Global Single Cell Bioinformatics Software and Services Market
11.17.3 Key Customers of the Company
11.18 Emerging Companies
11.18.1 Singleron Biotechnologies
11.18.2 Mission Bio
11.18.3 Dolomite Bio
11.18.4 Menarini Silicon Biosystems
11.18.5 Elucidata

List of Figures
Figure 1: Global Incidence of Cancer in Millions, 2014-2019
Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Single Cell Bioinformatics Software and Services Market
Figure 3: Global Single Cell Bioinformatics Software and Services Market (by Product), $Million, 2020 and 2031
Figure 4: Global Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 5: Global Single Cell Bioinformatics Software and Services Market (by End-User), $Million, 2020 and 2031
Figure 6: Global Single Cell Bioinformatics Software and Services Market Snapshot (by Region)
Figure 7: Global Single Cell Bioinformatics Software and Services Market Segmentation
Figure 8: Global Single Cell Software and Services Market: Research Methodology
Figure 9: Primary Research Methodology
Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
Figure 11: Top-Down Approach (Segment-Wise Analysis)
Figure 12: Global Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 13: Company Collaborations During COVID-19 (2020-2022)
Figure 14: Year-Wise Analysis of Patents Related to Single Cell Bioinformatics, January 2019-January 2022
Figure 15: Region-Wise Analysis of Patents Related to Single Cell Bioinformatics, January 2018-January 2022
Figure 16: Country-Wise Analysis of Patents Related to Single Cell Bioinformatics, January 2018-January 2022
Figure 17: Share of Key Developments and Strategies, January 2019-March 2022
Figure 18: Share of Acquisitions (by Company), January 2018-January 2021
Figure 19: Synergistic Activities Share (by Company), January 2018-March 2022
Figure 20: Product Launches and Upgradations (by Company), January 2018–March 2022
Figure 21: Share of Business Expansion Activities (by Company), January 2018-March 2022
Figure 22: Market Share Analysis for Global Single Cell Bioinformatics Software and Services Market, $Million, 2019 and 2020
Figure 23: Growth-Share Analysis of Global Single Cell Bioinformatics Software and Services Market (by Application), 2020-2031
Figure 24: Growth-Share Matrix for Global Single Cell Bioinformatics Software and Services Market (by End-user), 2020
Figure 25: Increasing Number of Single-Cell Bioinformatic Product Launches Over the Years (2017-2021)
Figure 26: Increasing Number of Publications with “Single Cell” Keyword Over the Years (2010-2021)
Figure 27: Total Single-Cell Multi-Omics Publications over the Years (2011-2021)
Figure 28: Total Single-Cell Spatial Transcriptomics Publications over the Years (2011-2021)
Figure 29: Global Single Cell Bioinformatics Software and Services Market (by Product)
Figure 30: Global Single Cell Bioinformatics Software and Services Market (by Product), $Million, 2020 and 2031
Figure 31: Global Single Cell Bioinformatics Software and Services Market (Bioinformatics Software), $Million, 2020-2031
Figure 32: Global Single Cell Bioinformatics Software and Services Market (Bioinformatics Services), $Million, 2020-2031
Figure 33: Global Single Cell Bioinformatics Software and Services Market (Genomics Analysis), $Million, 2020-2031
Figure 34: Single Cell Transcriptome Analysis of Tissues and Cell Types
Figure 35: Global Single Cell Bioinformatics Software and Services Market (Transcriptome Analysis), $Million, 2020-2031
Figure 36: Global Single Cell Bioinformatics Software and Services Market (Metabolomic Analysis), $Million, 2020-2031
Figure 37: Global Single Cell Bioinformatics Software and Services Market (Epigenomic Analysis), $Million, 2020-2031
Figure 38: Global Single Cell Bioinformatics Software and Services Market (Proteomic Analysis), $Million, 2020-2031
Figure 39: Global Single Cell Bioinformatics Software and Services Market (Other), $Million, 2020-2031
Figure 40: Global Single Cell Bioinformatics Software and Services Market (by Application)
Figure 41: Global Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 42: Global Single Cell Bioinformatics Software and Services Market (Oncology), $Million, 2020-2031
Figure 43: Global Single Cell Bioinformatics Software and Services Market (Immunology), $Million, 2020-2031
Figure 44: Global Single Cell Bioinformatics Software and Services Market (Neurology), $Million, 2020-2031
Figure 45: Global Single Cell Bioinformatics Software and Services Market (Non-invasive Prenatal Diagnosis), $Million, 2020-2031
Figure 46: Global Single Cell Bioinformatics Software and Services Market (Microbiology), $Million, 2020-2031
Figure 47: Global Single Cell Bioinformatics Software and Services Market (Others), $Million, 2020-2031
Figure 48: Global Single Cell Bioinformatics Software and Services Market (by End-User)
Figure 49: Global Single Cell Bioinformatics Software and Services Market (by End- User), $Million, 2020 and 2031
Figure 50: Global Single Cell Bioinformatics Software and Services Market (Biopharmaceutical Companies), $Million, 2020-2031
Figure 51: Global Single Cell Bioinformatics Software and Services Market (Research and Academic Institutes), $Million, 2020-2031
Figure 52: Global Single Cell Bioinformatics Software and Services Market (by Others), $Million, 2020-2031
Figure 53: Global Single Cell Bioinformatics Software and Services Market Snapshot (by Region)
Figure 54: Global Single Cell Bioinformatics Software and Services Market (by Region), $Million, 2020-2031
Figure 55: Global Single Cell Bioinformatics Software and Services Market (by Region), 2020 and 2031
Figure 56: North America Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 57: North America Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 58: North America Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020-2031
Figure 59: U.S. Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 60: Canada Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 61: Europe Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 62: Europe Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 63: Europe Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020–2031
Figure 64: Germany Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 65: France Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 66: U.K. Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 67: Italy Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 68: Spain Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 69: Rest-of-Europe Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 70: Asia-Pacific Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 71: Asia-Pacific Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 72: Asia-Pacific Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020-2031
Figure 73: Japan Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 74: China Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 75: Australia Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 76: India Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 77: South Korea Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 78: Rest-of-Asia-Pacific Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 79: Latin America Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 80: Latin America Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 81: Latin America Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020-2031
Figure 82: Brazil Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 83: Mexico Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 84: Rest-of-Latin America Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 85: Rest-of-the-World World Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 86: Rest-of-the-World Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 87: Total Number of Companies Profiled
Figure 88: Global Single Cell Bioinformatics Software and Services Market: Value Chain
Figure 89: Illumina, Inc.: Products & Services Portfolio
Figure 90: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 91: Illumina, Inc.: Revenue (by Business Segment), $Million, 2019-2021
Figure 92: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 93: Illumina, Inc.: R&D Expenditure, $Million, 2019-2022
Figure 94: Illumina, Inc.: SWOT Analysis
Figure 95: QIAGEN N.V.: Products Portfolio
Figure 96: QIAGEN N.V.: Overall Financials, $Million, 2018-2020
Figure 97: QIAGEN N.V.: Revenue (by Business Segment), $Million, 2018–2020
Figure 98: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020
Figure 99: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020
Figure 100: QIAGEN N.V.: SWOT Analysis
Figure 101: BD.: Product Portfolio
Figure 102: BD.: Overall Financials, $Million, 2019-2021
Figure 103: BD.: Revenue (by Business Segment), $Million, 2018–2020
Figure 104: BD.: Revenue (by Region), $Million, 2018-2020
Figure 105: BD.: R&D Expenditure, $Million, 2018-2020
Figure 106: BD.: SWOT Analysis
Figure 107: PacBio: Product Portfolio
Figure 108: PacBio: Overall Financials, $Million, 2018-2020
Figure 109: PacBio: Revenue (by Business Segment), $Million, 2018–2020
Figure 110: PacBio: Revenue (by Region), $Million, 2018-2020
Figure 111: PacBio: R&D Expenditure, $Million, 2018-2020
Figure 112: PacBio: SWOT Analysis
Figure 113: Fluidigm Corporation: Product Portfolio
Figure 114: Fluidigm Corporation: Overall Financials, $Million, 2018-2020
Figure 115: Fluidigm Corporation: Revenue (by Business Segment), $Million, 2018–2020
Figure 116: Fluidigm Corporation: Revenue (by Region), $Million, 2018-2020
Figure 117: Fluidigm Corporation: R&D Expenditure, $Million, 2018-2020
Figure 118: Fluidigm Corporation: SWOT Analysis
Figure 119: NanoString: Product Portfolio
Figure 120: NanoString: Overall Financials, $Million, 2018-2020
Figure 121: NanoString: Revenue (by Business Segment), $Million, 2018–2020
Figure 122: NanoString: Revenue (by Region), $Million, 2018-2021
Figure 123: NanoString: R&D Expenditure, $Million, 2018-2020
Figure 124: NanoString: SWOT Analysis
Figure 125: Takara Bio Inc.:Product Portfolio
Figure 126: Takara Bio Inc.: Overall Financials, $Million, 2019-2021
Figure 127: Takara Bio Inc.: Revenue (by Business Segment), $Million, 2019–2021
Figure 128: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2021
Figure 129: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2021
Figure 130: Takara Bio Inc.: SWOT Analysis
Figure 131: BGI: Product Portfolio
Figure 132: BGI: SWOT Analysis
Figure 133: Oxford Nanopore Technologies, plc.: Product Portfolio
Figure 134: Oxford Nanopore Technologies plc.: Overall Financials, $Million, 2018-2020
Figure 135: Oxford Nanopore Technologies plc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 136: Oxford Nanopore Technologies plc.: Revenue (by Region), $Million, 2019-2021
Figure 137: Oxford Nanopore Technologies plc.: R&D Expenditure, $Million, 2020-2021
Figure 138: Oxford Nanopore Technologies plc.: SWOT Analysis
Figure 139: Partek, Incorporated: Product Portfolio
Figure 140: Partek, Incorporated: SWOT Analysis
Figure 141: Akoya Biosciences, Inc.: Product Portfolio
Figure 142: Akoya Biosciences, Inc.: SWOT Analysis
Figure 143: IsoPlexis: Product Portfolio
Figure 144: IsoPlexis SWOT Analysis
Figure 145: Scipio Biosciences: Product Portfolio
Figure 146: Scailyte: Product Portfolio
Figure 147: BioBam Spain: Product Portfolio

List of Tables
Table 1: Likert Scale
Table 2: Impact Analysis of Market Drivers
Table 3: Impact Analysis of Market Restraints
Table 4: Bioinformatics Sequence Analysis Software Offered by Key Players
Table 5: Biopharmaceutical Companies and Providers
Table 6: Research and Academic Institutes and Providers
Table 7: North America: Market Dynamics
Table 8: Europe: Market Dynamics
Table 9: Asia-Pacific: Market Dynamics
Table 10: Latin America: Market Dynamics

Companies Mentioned

  • Illumina, Inc.
  • QIAGEN N.V.
  • BD
  • PacBio
  • Fluidigm Corporation
  • NanoString
  • Takara Bio Inc.
  • BGI
  • Oxford Nanopore Technologies plc.
  • Partek, Incorporated
  • Akoya Biosciences, Inc.
  • IsoPlexis
  • Scipio Bioscience
  • Scailyte
  • BioBam Spain